Terns Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

DB:430 Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
02 Jan 26	Sell€6,743	Emil Kuriakose	Individual	200	€33.72
02 Jan 26	Sell€31,189	Emil Kuriakose	Individual	955	€32.66
01 Oct 25	Sell€6,314	Emil Kuriakose	Individual	944	€6.69
01 Jul 25	Sell€3,092	Emil Kuriakose	Individual	853	€3.62
27 Jun 25	Buy€33,528	Andrew Gengos	Individual	10,000	€3.35
25 Jun 25	Buy€77,607	Amy Burroughs	Individual	23,314	€3.33
16 Jun 25	Buy€49,256	Andrew Gengos	Individual	15,000	€3.41
01 Apr 25	Sell€2,189	Emil Kuriakose	Individual	952	€2.30

Insider Trading Volume

Insider Buying: 430 insiders have only sold shares in the past 3 months.

Ownership Breakdown

What is the ownership structure of 430?
Owner Type	Number of Shares	Ownership Percentage
Individual Insiders	340,140	0.313%
Hedge Funds	13,827,100	12.7%
VC/PE Firms	14,390,746	13.2%
General Public	22,093,398	20.3%
Institutions	58,115,897	53.4%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 28.1%.

Top Shareholders

Top 25 shareholders own 70.87% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
7.47%	Soleus Capital Management, L.P.	8,127,100	€238.3m	-0.49%	10.51%
6.94%	Morgan Stanley	7,543,167	€221.2m	4.65%	0.02%
6.89%	Deep Track Capital, LP	7,495,000	€219.8m	0%	4.57%
6.34%	Vivo Capital, LLC	6,895,746	€202.2m	0%	13.65%
5.24%	Commodore Capital LP	5,700,000	€167.1m	0%	8.02%
5.1%	BlackRock, Inc.	5,551,308	€162.8m	1.48%	no data
5.08%	The Vanguard Group, Inc.	5,523,948	€162.0m	21.1%	no data
4.03%	OrbiMed Advisors LLC	4,386,778	€128.6m	-42%	2.01%
3.62%	Adage Capital Management, L.P.	3,939,000	€115.5m	208%	0.21%
2.18%	Candriam, Société En Commandite Par Actions	2,368,235	€69.4m	0%	0.21%
1.81%	Acorn Bioventures	1,971,264	€57.8m	0%	24.55%
1.74%	Schonfeld Strategic Advisors LLC	1,891,925	€55.5m	-38%	0.45%
1.58%	Geode Capital Management, LLC	1,714,552	€50.3m	4.97%	no data
1.48%	State Street Global Advisors, Inc.	1,605,693	€47.1m	16.9%	no data
1.46%	Citadel Advisors LLC	1,589,334	€46.6m	-59.2%	0.04%
1.45%	Pictet Asset Management Limited	1,577,116	€46.2m	42.8%	0.04%
1.35%	Teachers Insurance and Annuity Association-College Retirement Equities Fund	1,469,371	€43.1m	24.9%	0.01%
1.34%	Dimensional Fund Advisors LP	1,456,401	€42.7m	-11.8%	0.01%
1.17%	Franklin Resources, Inc.	1,277,396	€37.5m	0%	0.01%
0.87%	Integral Health Asset Management, LLC	950,000	€27.9m	35.7%	2.12%
0.87%	Millennium Management LLC	941,584	€27.6m	-5.54%	0.02%
0.86%	Parkman Healthcare Partners LLC	934,760	€27.4m	14.3%	3.18%
0.73%	Superstring Capital Management LP	789,646	€23.2m	-38.6%	21.23%
0.65%	Bank of America Corporation	704,771	€20.7m	42.7%	0.01%
0.62%	Renaissance Technologies LLC	676,834	€19.8m	-26.6%	0.03%

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2026/02/02 23:15
End of Day Share Price	2026/02/02 00:00
Earnings	2025/09/30
Annual Earnings	2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Terns Pharmaceuticals, Inc. is covered by 17 analysts. 9 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Etzer Darout	Barclays
Etzer Darout	BMO Capital Markets Equity Research
Evan Seigerman	BMO Capital Markets Equity Research